Agile Therapeutics Inc logo

Agile Therapeutics Inc

$ 0.31 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
1.09
Market Cap:
$ 11.90M
Enterprise V:
$ 12.37M
Volume:
518.77K
Avg Vol (2M):
2.70M
Also Trade In:
Volume:
518.77K
Market Cap $:
11.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.70M
Enterprise Value $:
12.37M
PB Ratio:
1.09
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
Name Current Vs Industry Vs History
Cash-To-Debt 0.97
Equity-to-Asset 0.1
Debt-to-Equity 3.95
Debt-to-EBITDA -0.22
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -24
Distress
Grey
Safe
Beneish M-Score -2.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.77
9-Day RSI 35.94
14-Day RSI 33.56
6-1 Month Momentum % -95.1
12-1 Month Momentum % -99.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.64
Quick Ratio 0.56
Cash Ratio 0.45
Days Inventory 77.5
Days Sales Outstanding 84.71
Days Payable 253.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -52.3
Name Current Vs Industry Vs History
Gross Margin % -81.97
Operating Margin % -973.43
Net Margin % -958.69
ROE % -632.04
ROA % -168.35
ROIC % -241.98
ROC (Joel Greenblatt) % -500.27
ROCE % -381.52

Financials (Next Earnings Date:2022-11-02 Est.)

AGRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AGRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.688
EPS (TTM) ($) -21.69
Beta 1.81
Volatility % 61.49
14-Day RSI 33.56
14-Day ATR ($) 0.033764
20-Day SMA ($) 0.341755
12-1 Month Momentum % -99.04
52-Week Range ($) 0.262 - 40.4
Shares Outstanding (Mil) 39.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Agile Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Agile Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.